Inventor

Eckhard Ottow

Inventor
Berlin, DE

Overview

39→
Patents
1989–2010
Patent span
Chemistry
Primary field (CPC C)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07JSteroids32%
C07DHeterocyclic compounds11%
A61KPreparations for medical, dental or toiletry purposes8%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
C40BCombinatorial chemistry1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
7,659,364'N-methyl-homocysteines and their use as well as process for their production'20107,479,491'Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors'20097,321,044'Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens'20087,297,702'Contraception method using competitive progesterone antagonists and novel compounds useful therein'20077,122,547'Anthranilic acid amides and the use thereof as medicaments'20066,949,655'Acyclic piperidine derivatives'20056,818,661'Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors'20046,790,853'Contraception method using competitive progesterone antagonists and novel compounds useful therein'20046,608,074'Contraception method using competitive progesterone antagonists and novel compounds useful therein'20036,596,713'Steroid esters and amides, process for their production and their pharmaceutical use'20036,340,688'Contraception method using competitive progesterone antagonists and novel compounds useful therein'20026,284,779'Heteroaromatic compounds'20016,143,733'Quinoxalinedione derivatives, their production and use in pharmaceutical agents'20006,136,805'Quinoxaline dione derivatives, their production and their use in medicaments'20006,127,368'Anellated .beta.-carbolines'20006,096,732'Steroid esters, process for their production and their pharmaceutical use'20006,025,376'Chiral methylphenyloxazolidinones'20005,843,933'11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents'19985,843,931'6,7-modified 11.beta.-aryl-4-oestrenes'19985,728,689'11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents'19985,703,066'Progestationally active 19,11-bridged 4-estrenes'19975,523,298'Progestationally active 19,11-bridged 4-estrenes'19965,519,027'D-homo-(16-ene)-11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents'19965,446,178'Process for preparing 19,11.beta.-bridged steroids'19955,446,036'13-alkyl-11beta-phenylgonanes'19955,439,913'Contraception method using competitive progesterone antagonists and novel compounds useful therein'19955,426,102'14.beta.-H-, 14-and 15-En-11.beta.-aryl-4-oestrenes'19955,405,979'Process for the production of 10.beta.-H-steroids'19955,359,054'Initial compounds for the production of 10.beta.-H-steroids and a process for the production of these initial compounds'19945,273,971'13-alkyl-11.beta.-phenylgonanes'19935,244,886'11.beta.-phenyl-14.beta.H steroids'19935,232,915'9.alpha.-hydroxy-19,11.beta.-bridged steroids, their production and pharmaceutical preparations containing these steroids'19935,132,299'11.beta.-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same'19925,095,129'19,11 .beta.-bridged steroids, their manufacture and pharmaceutical preparations containing them'19925,093,507'10.beta.,11.beta.-bridged steroids'19925,089,488'.beta.-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same'19924,870,069'11.beta.-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing them'19894,829,060'11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing them'19894,814,327'11 .beta.-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–2008Patents assigned to SCHERING AG (32)· patent assignee history
1989–2010Based in Berlin, DE· patent location history
2004–2009Patents assigned to NOVARTIS AG (3)· patent assignee history
2005Patents assigned to BOTFIELD MARTYN (1)· patent assignee history
2005Patents assigned to LAUFFER DAVID (1)· patent assignee history
2010Patents assigned to CIS BIO INT (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SCHERING AG321989–2008
NOVARTIS AG32004–2009
BOTFIELD MARTYN12005
CIS BIO INT12010
LAUFFER DAVID12005
Locations
LocationPatentsSpan
Berlin, DE391989–2010